PTCT

PTC Therapeutics, Inc.

1 day chart

About PTCT

PTC Therapeutics, Inc. is a science-driven, global biopharmaceutical company. The Company is focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. Its portfolio pipeline includes several commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology, metabolism and oncology. The Company has two products, Translarna (ataluren) and Emflaza (deflazacort), for the treatment of Duchenne muscular dystrophy (DMD). It also offers Upstaza, a gene therapy for the treatment of Aromatic L-Amino Decarboxylase (AADC) deficiency, and Evrysdi, a treatment for spinal muscular atrophy (SMA). Its splicing platform includes PTC518, which is being developed for the treatment of Huntington’s disease (HD).

Buy US stocks in Australia starting with PTCT. Open an account and start investing today!

Market Capitalisation

$1.71B

Price-earnings ratio

Dividend yield

0.00%

Volume

1.33M

High today

$22.31

Low today

$21.03

Open price

$22.31

52-week high

$59.84

52-week low

$22.03

PTCT FAQs

Can I buy PTCT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy PTCT shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of PTC Therapeutics, Inc.?

One share of PTC Therapeutics, Inc. is valued at $39.59.

What is the ticker symbol for PTC Therapeutics, Inc.?

The ticker symbol for PTC Therapeutics, Inc. is PTCT.

How do I buy PTCT shares in Australia?

To buy PTCT stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in PTCT

What is the 52-week high for PTC Therapeutics, Inc. stock?

The PTC Therapeutics, Inc. 52-week high stock price is $59.84.

What is the 52-week low for PTC Therapeutics, Inc. stock?

The PTC Therapeutics, Inc. 52-week low stock price is $22.03.

What is the market capitalisation of PTC Therapeutics, Inc. PTCT?

As of 02/10/2023 PTC Therapeutics, Inc. has a market cap of $1.7B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.